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Manchester University National Health Service Foundation Trust, Manchester Academic Health Science Centre, Manchester, UKNephrons scar and involute during aging, increasing the
risk of chronic kidney disease. Little is known, however,
about genetic mechanisms of kidney aging. We sought to
deﬁne the signatures of age on the renal transcriptome
using 563 human kidneys. The initial discovery analysis of
260 kidney transcriptomes from the TRANScriptome of
renaL humAn TissuE Study (TRANSLATE) and the Cancer
Genome Atlas identiﬁed 37 age-associated genes. For 19 of
those genes, the association with age was replicated in 303
kidney transcriptomes from the Nephroseq resource.
Surveying 42 nonrenal tissues from the Genotype–Tissue
Expression project revealed that, for approximately a ﬁfth
of the replicated genes, the association with age was
kidney-speciﬁc. Seventy-three percent of the replicated
genes were associated with functional or histological
parameters of age-related decline in kidney health,
including glomerular ﬁltration rate, glomerulosclerosis,
interstitial ﬁbrosis, tubular atrophy, and arterial narrowing.
Common genetic variants in four of the age-related genes,
namely LYG1, PPP1R3C, LTF and TSPYL5, correlated with the
trajectory of age-related changes in their renal expression.
Integrative analysis of genomic, epigenomic, and
transcriptomic information revealed that the observed age-Correspondence: M Tomaszewski, Division of Cardiovascular Sciences,
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624related decline in renal TSPYL5 expression was determined
both genetically and epigenetically. Thus, this study
revealed robust molecular signatures of the aging kidney
and new regulatory mechanisms of age-related change in
the kidney transcriptome.
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j.kint.2018.10.029
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A ging is associated with a decline in health and integrityof the human kidney.1 Indeed, from the fourth decadeof life, the glomerular ﬁltration rate falls by 8 ml/min
per 1.73 m2 every 10 years.2 Moreover, the kidney undergoes
structural remodeling with age.3,4 Macroscopically, kidney
mass and blood ﬂow decline with age.3,5,6 These changes are
likely to contribute to the known increase in risk of chronic
kidney disease (CKD) with age.7
Genetic mechanisms may impact renal aging, and previous
gene expression proﬁling experiments highlighted molecules
associated with the development of age-related changes in the
kidney.8,9 These studies had several caveats: they used small
numbers of samples, typically fewer than 100; lacked robust
replication in independent cohorts; and used microarrays to
quantify the expression of genes in the kidney. In contrast to
microarrays, next-generation RNA-sequencing (RNA-seq)
allows for an unbiased hypothesis-free approach toKidney International (2019) 95, 624–635
J Rowland et al.: Genes, aging, and the kidney c l i n i ca l i nves t iga t iontranscriptome proﬁling and increased sensitivity to detect
changes in genes with low levels of expression such as long
noncoding RNAs.10,11 Thus, previous studies may not have
deﬁned certain genes relevant to kidney aging because of
limitations in technology or sample size, whereas the genes
that were identiﬁed were not replicated in other populations.
It also is unclear whether the expression of age-associated
kidney genes is controlled, at least in part, by genetically and/or
epigenetically inherited variations in DNA. Single differences in
DNA sequences determine phenotypic variation in health and
disease, for example, through differential effects on gene expres-
sion.12,13 Several recent studies have reported associations be-
tween common single-nucleotide polymorphisms (SNPs) and
human aging,14 as well as renal gene expression.15 Epigenetic
modiﬁcations, such as DNA methylation, also can modify gene
expression.16 Indeed, aging is accompanied by genome-wide
hypomethylation and site-speciﬁc hypermethylation, at least in
nonrenal tissues.17 The age-related changes in regional 50—C—
phosphate—G—30 site (CpG) methylation across tissues have
been used to derive a global epigenetic signature as a measure of
biological age.18,19 Nevertheless, patterns of DNAmethylation are
highly variable across different tissues and a majority of methyl-
ation studies have been conducted on tissues other than the
kidney.20
In this study, we identiﬁed robust signatures of age on the
renal transcriptome by studying a large assembly of human
kidneys characterized by RNA-seq. We identiﬁed several genes
that showed similar age-related changes across different human
tissues, while others represented kidney-speciﬁc aging signatures.
We also found associations between these signatures and certain
functional and structural measures of kidney health. Finally, by
integrating genomic, epigenomic, and transcriptomic informa-
tion, we uncovered new regulatory mechanisms underlying the
expression of age-related signatures in the human kidney.
RESULTS
Signatures of age on kidney transcriptome: discovery analysis
The design and delivery of the project is shown in the ﬂow chart
in Figure 1. In total, 160 patients from the TRANScriptome of
renaL humAn TissuE (TRANSLATE) Study and 100 individuals
from The Cancer Genome Atlas (TCGA) were included in the
discovery analysis. The clinical characteristics of both studies are
shown inTable 1. A total of 15,791kidney genes common toboth
data sets were included in the analysis. After correction for
multiple testing, 37 genes were associated with age (Figure 2,
Supplementary Figure S1, and Supplementary Table S1). Of
these, 33were protein-coding and 4 were long noncoding RNAs.
Biological characteristics of these genes are shown in
Supplementary Table S2. Only 1 gene, EGF, overlapped with 307
genes implicated in aging from the GenAge database.21 Taking
advantage of clinical information available in the TRANSLATE
Study, we further examined the potential effects of common
cofounders or comorbidities on the association between age and
renal gene expression. The sensitivity analysis showed that after
adjusting for body mass index, hypertension, and diabetes
mellitus, 30 of the 37 genes (81%) retained associations with ageKidney International (2019) 95, 624–635in the TRANSLATE Study at the nominal level of statistical sig-
niﬁcance of 5% (Supplementary Table S3).
Signatures of age on kidney transcriptome: replication
analysis
We identiﬁed a total of 303 glomerular/renal cortex
transcriptomes and 299 tubulointerstitial/renal medulla tran-
scriptomes from eligible studies in Nephroseq.22 Of 37 age-
associated genes, 32 were available for replication. Separate
meta-analyses of renal cortex and medulla showed 12 and 18
associations with age, respectively, after correction for multiple
testing (Supplementary Tables S4 and S5). A total of 19 kidney
genes (59.3% of those available for this analysis) associated with
age in the discovery analysis replicated in the same direction of
association in Nephroseq (Figure 2). Additional sensitivity anal-
ysis showed that most (60%) of the age-associated genes that
replicated exclusively in apparently healthy kidney tissues8
overlapped with those identiﬁed in the replication limited to
samples from patients with kidney disease.23,24
Ubiquitous and kidney-speciﬁc gene signatures of aging
Three (16%) of the replicated genes, EGF, EDH3, and LYG1,
showed enriched kidney RNA/protein expression in the Human
Protein Atlas25 (Supplementary Table S2). Although most of the
age-associated kidney genes were abundant in other tissues, we
reasoned that age-related changes in expression of these genes
may be different compared with nonrenal tissues. To identify
genes correlating with age exclusively in the kidney, we ﬁrst
conducted an association analysis between age and gene
expression in 42 nonrenal Genotype–Tissue Expression (GTEx)
project tissues from 532 individuals. The overview of the tissues
included in this analysis and the demographic characteristics of
the GTEx subjects are shown in Supplementary Tables S6 and
S7. This analysis showed between 0 and 276 associations of age
with gene expression in different tissues (Supplementary
Table S6). All of our 19 replicated kidney genes were available
for an overlap analysis with the transcriptomic signatures of age
in the GTEx project (Supplementary Table S8). Under the
initially selected statistical criteria, 15 (79%) of these showed no
overlap with age-associated GTEx genes in this analysis (Figure 2
and Supplementary Table S8). Further sensitivity analyses were
conducted under several alternative scenarios, with a different
number of probabilistic estimations of expression residuals–
derived factors in the nonrenal GTEx tissues. These showed
that only 5 genes, comprising 26% of the replicated genes,
showed no association with age in any of the statistical scenarios
in any nonrenal tissues (Supplementary Table S9). As such, these
genes, EDH3, ERP27, MAP4, PPP1R3C, and SNX24, represent
tissue-speciﬁc signatures of age on the kidney transcriptome.
Robust gene signatures of kidney aging and their correlation
with functional and structural dimensions of kidney health
Of 19 replicated genes, 14 showed at least 1 nominally signiﬁcant
association with 1 of 5 biochemical or histologic measures of
renal functional and structural integrity known to deteriorate
with age (i.e., estimated glomerular ﬁltration rate,625
Figure 1 | Illustration of key stages of the project together with the main outcomes. TCGA, The Cancer Genome Atlas; TRANSLATE Study,
TRANScriptome of renaL humAn TissuE Study; Nephroseq renal cortex, a combination of 3 separate studies of renal cortex/glomerulus from
Nephroseq resource; Nephroseq renal medulla, a combination of 3 separate studies of renal medulla/tubulointerstitium from Nephroseq resource;
GTEx, Genotype–Tissue Expression project; cis-eQTL, cis-expression quantitative trait locus; cis-mQTL, cis-methylation quantitative trait locus;
eGene, gene whose renal expression is associated with at least 1 single-nucleotide polymorphism in-cis after correction for multiple testing;
mSNP, gene whose renal DNA methylation is associated with at least 1 single-nucleotide polymorphism in-cis after correction for multiple
testing; CPG, 5’—C—phosphate—G—3’ site; eSNP, transcriptionally active single-nucleotide polymorphism.
c l i n i ca l i nves t iga t i on J Rowland et al.: Genes, aging, and the kidneyglomerulosclerosis, tubular atrophy, interstitial ﬁbrosis, and
arterial/arteriolar narrowing) in up to 160 individuals from the
TRANSLATE Study (Supplementary Tables S10–S14, Figure 2,
and Supplementary Figure S2). The direction of these asso-
ciations was always consistent with the expected age-related
decline in kidney health. After correction for multiple
testing, 10 genes retained their statistically signiﬁcant associ-
ations with at least 1 measure of kidney health
(Supplementary Tables S10–S14 and Supplementary
Figure S2), as follows: ATP1B2, EGF, EHD3, MAP4, SLPI,
TMEM54, SLC16A5, ZNF518B, TRIM26, and TSPYL5. Sta-
tistically, the most signiﬁcant relationship was detected be-
tween decreasing kidney expression of TSPYL5 and increasing626arterial/arteriolar narrowing (P ¼ 6.3  10-5, false discovery
rate, 0.0015) (Supplementary Table S14). Further sensitivity
analyses showed that age adjustment reduced or completely
abolished the statistical signiﬁcance of all genes
(Supplementary Tables S10–S14), consistent with a key role of
aging in the uncovered associations between renal gene
expression and indices of kidney health.
Cross-species validation of age-related human kidney genes
in rodents
Of 19 genes showing association with human age at the renal
expression level, 8 had murine homologs (Egf, Ltf, Lyg1,
Phlda3, Slc16a5, Slpi, Snx24, and Vim) proﬁled on the geneKidney International (2019) 95, 624–635
Table 1 | Demographic and selected clinical characteristics of
the TRANSLATE Study and TCGA
Characteristics TRANSLATE Study TCGA
N 160 100
Age, yr 63.2  10.4 61.4  13.3
Age range, yr 30–87 28–86
Male sex 99 (62%) 69 (69%)
White–European ethnicity 160 (100%) 100 (100%)
Body mass index, kg/m2 28.2  5.2 –
Hypertension 116 (73%) –
Diabetes 29 (18%)
eGFR, ml/min per 1.73 m2 75.3  19.1 –
Glomerular sclerosis 59/82/13/0 –
Interstitial ﬁbrosis 70/70/14/0 –
Tubular atrophy 67/69/17/1 –
Arterial/arteriolar narrowing 15/94/39/6 –
eGFR, estimated glomerular ﬁltration rate; TCGA, The Cancer Genome Atlas;
TRANSLATE, TRANScriptome of renaL humAn TissuE Study.
Data are counts (and percentages where appropriate), means and SDs or ranges. For
histologic phenotypes (n ¼ 154), data are numbers with Remuzzi’s scale from 0 to 3
(0/1/2/3), where 0 indicates none to minimal damage and 3 indicates maximal
damage.
J Rowland et al.: Genes, aging, and the kidney c l i n i ca l i nves t iga t ionexpression microarray/available for in silico replication.26 The
renal expression of 4 of these genes (Egf, Phlda3, Slpi, and
Vim) showed a statistically signiﬁcant association with murine
age, at least at the nominal level of statistical signiﬁcance
(Supplementary Table S15). Phlda3, Slpi, and Vim also were
associated with the histologic measure of age-related decline
in kidney health, namely glomerular membrane thickening
and tubular degeneration, in mice (Supplementary
Table S15). In the absence of availability of TSPYL5 for vali-
dation in mice, we measured age-related changes in the
expression of this gene in rat kidneys.27 This analysis showed
reduced renal expression of TSPYL5 with age (Supplementary
Figure S3). Collectively, these studies show a high level,
approximately 50%, of cross-species replication of age-related
kidney genes between man and rodents.
Immunohistochemistry of TSPYL5 in human kidneys
In kidneys from 9 TRANSLATE Study individuals, immu-
nostaining for TSPYL5 detected a common pattern of signals
in tubules, in a cytoplasmic location, with 2 representative
samples shown in Figure 3. Further quantitative analysis of
TSPYL5 immunostaining showed numerically lower signal
intensity in kidneys from older individuals (age, >60 yr)
when compared with those younger than 60 years, but the
difference was not statistically signiﬁcant (P ¼ 0.176)
(Supplementary Figure S4).
Genetic regulation of renal expression of age-associated
genes
To determine the extent of genotype-dependent variation in
the expression of the 19 age-associated genes, we performed
in-cis meta-expression quantitative trait locus analysis of the
TRANSLATE Study and TCGA data with a window of 1 Mb.
After correction for multiple testing, 4 (21%) genes, LTF,
LYG1, PPP1R3C, and TSPYL5, showed signiﬁcant correlations
with 797 variants in-cis (Table 2 and SupplementaryKidney International (2019) 95, 624–635Tables S16 and S17). All most signiﬁcant variants (best
transcriptionally active single-nucleotide variants–best
eSNPs) mapped to noncoding regions of the genome; 3 of
them within actively transcribed chromatin regions in adult
kidney tissue (Supplementary Table S18). Genotypes of the
best eSNPs showed fairly constant effects on the age-related
changes in renal gene expression (Supplementary
Figure S5). We further examined associations between the
genotypes of 797 PPP1R3C, TSPYL5, LYG1, and LTF eSNPs
and estimated the glomerular ﬁltration rate in 110,527 in-
dividuals from the CKDGen Consortium.28 Of 723 variants
available for analysis, 105, 55, and 4 eSNPs in PPP1R3C,
TSPYL5, and LYG1, respectively, showed an association with
estimated glomerular ﬁltration rate in the CKDGen Con-
sortium, at least at the nominal level of statistical signiﬁcance
(Supplementary Table S19). The best eSNPs of PPP1R3C
(rs7077656) and TSPYL5 (rs2567772) were among the
eSNPs associated with an estimated glomerular ﬁltration
rate in the CKDGen Consortium. Thus, many genetic
variants that control expression changes of kidney aging
genes also are associated with a surrogate of kidney
function.
DNA methylation of age-associated genes and their
expression
To investigate possible effects of DNA methylation on gene
expression, we examined whether differences in CpG
methylation of kidney DNA in proximity to 19 age-associated
genes correlate with their renal expression in 78 TRANSLATE
Study individuals. We examined the extent of DNA methyl-
ation in all CpG sites mapping to 1000 base pairs from either
side of the age-associated gene. After correction for multiple
testing, methylation of 1 gene, TSPYL5, showed an inverse
association with its renal expression; the strongest association
was identiﬁed for cg22328208 probe mapping to the TSPYL5
promoter (P ¼ 2.310-4, Permutation P [Pperm] ¼ 1  10-3,
false discovery rate, 0.019) (Table 3, Supplementary
Table S20, and Figure 4). We further conﬁrmed that
methylation of the TSPYL5 promoter was associated with a
reduction in its expression using data generated in in vitro
experiments (Supplementary Table S21).
Association between age, renal methylation, and expression
of TSPYL5
We detected the association between age and 3 CpG probes
associated with the expression of TSPYL5 in 93 TRANSLATE
Study individuals (Supplementary Table S22). The positive
association of cg22328208 methylation with age is in agree-
ment with the demonstrated negative association between
renal expression of TSPYL5 and a decrease in the kidney
abundance of TSPYL5 with age (Table 3, Supplementary
Table S22, and Figure 4). We then conﬁrmed the associa-
tion between cg22328208 methylation and age in an inde-
pendent collection of 126 kidney samples from TCGA
(Supplementary Table S23). Further mediation analysis in the
TRANSLATE Study showed that the effect of age on627
Figure 2 | Overview of kidney genes associated with age. Chromosome numbers appear at the top of the circle and proceed clockwise.
Track 1: The level of statistical signiﬁcance (-log10 P values) from meta-analysis of association between renal gene expression and age in the
TRANScriptome of renaL humAn TissuE (TRANSLATE) Study and The Cancer Genome Atlas (TCGA). Track 2: Symbols of 37 kidney genes
associated with age in the meta-analysis of the TRANSLATE Study and TCGA after the correction for multiple testing. Track 3: Direction of
association between expression of a gene and age (based on b-coefﬁcients from the meta-analysis of the TRANSLATE Study and TCGA). Yellow,
positive: gene is upregulated with increasing age; pink, negative: gene is downregulated with increasing age. Track 4: Prior evidence for as-
sociation with aging determined via search of PubMed, GenAge, and AgeMap databases. Blue, genes previously associated with age; orange, no
previous association with age. Track 5: Kidney genes associated with age in Nephroseq resource (red). Track 6: Kidney-speciﬁc (in purple) and
ubiquitous (in green) signatures of age (based on the analysis of nonrenal tissues). Tracks 7 to 11: Associations between replicated age-related
kidney genes and estimated glomerular ﬁltration rate (track 7), glomerulosclerosis (track 8), interstitial ﬁbrosis (track 9), tubular atrophy (track
10), and arterial/arteriolar narrowing (track 11). At least nominally signiﬁcant associations are shown in blue.
c l i n i ca l i nves t iga t i on J Rowland et al.: Genes, aging, and the kidneycg22328208 is primary to changes in TSPYL5 expression in
the kidney (P ¼ 0.0118) (Figure 4). Collectively, these data
show that age-related increase in methylation of the TSPYL5
promoter in the kidney translates into a decrease in the renal
expression of TSPYL5.
Genotype-dependent effect on kidney DNA methylation of
TSPYL5
Genetic variation is known as one of the regulatory mecha-
nisms for CpG methylation in human tissues. Therefore, we
sought to identify common variants associated with methyl-
ation of cg22328208 in 93 TRANSLATE Study individuals.
This cis-methylation quantitative trait locus analysis used a
window of 33,172 base pairs, the maximum distance between
TSPYL5 and its eSNPs plus its own length, from the target
CpG site and showed that after correction for multiple
testing, cg22328208 was associated with 70 SNPs
(Supplementary Table S24). The strongest association was
identiﬁed for rs1367917 (Figure 4). These data conﬁrmed that628interindividual differences in renal DNA methylation of
TSPYL5 are dependent on genotype.
Mediation analysis and causality between kidney methylation
and expression of TSPYL5
We jointly investigated the identiﬁed cis-expression quanti-
tative trait locus and cis-methylation quantitative trait locus of
TSPYL5 in 93 TRANSLATE Study samples that had infor-
mative eQTL and mQTL data: 62 of 65 eSNPs overlapped
with the set of 70 single-nucleotide variants with effect on
methylation (mSNPs) (Supplementary Table S25). The
mediation analysis based on the set of overlapping SNPs,
TSPYL5 methylation, and expression was consistent with the
epigenetic mediation model: both the best mSNP (rs1367917;
P ¼ 1.07  10-6) and the best eSNP (rs2567772; P ¼ 1.32 
10-3) were linked to TSPYL5 expression through cg22328208
methylation (Figure 4). Further Mendelian randomization
using TSPYL5 SNPs as instruments, cg22328208 methylation
as exposure, and TSPYL5 expression as outcome, and bothKidney International (2019) 95, 624–635
Figure 3 | Immunohistochemistry of TSPYL5 in human kidneys. (a,b,e,f) Sections were immunostained for TSPYL5 (brown signal), (c,d)
except where the primary antibody was omitted. All sections were counterstained with hematoxylin (blue nuclei). (a) Low-power overview of
kidney cortex of a 58-year-old individual showing glomeruli and tubules. (b) High-power view of boxed area in panel a. Larger tubules (t) have
prominent TSPYL5 immunostaining, with a cytoplasmic pattern. Smaller tubules (arrows) in the ﬁbrotic area (*) appear to have less prominent
TSPYL5 signals. (c,d) Negative controls in which goat anti-rabbit secondary antibody was applied but the primary antibody was omitted.
(e) Low-power overview of kidney cortex of an 81-year-old individual showing prominent zones of atrophic tubules and ﬁbrosis. (f) High-power
view from sample in panel e: in some tubules TSPYL5 signals appear conﬁned to a subset of cells (arrow). Bars ¼ (a,c,e) 200 mm, and (b,d,f)
50 mm. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org.
J Rowland et al.: Genes, aging, and the kidney c l i n i ca l i nves t iga t ioninverse variance weighting and weighted median methods
showed a causal effect of cg22328208 methylation on renal
TSPYL5 expression; the effect estimates were -0.563 (95%
conﬁdence interval, -0.326 to -0.801) and -0.655 (95% con-
ﬁdence interval, -0.071 to -1.24) (Figure 4). The Mendelian
randomization–Egger regression indicated that there was no
pleiotropy of the instruments (P ¼ 0.291).
Functional analysis of TSPYL5 locus in silico
We used Roadmap Epigenomics chromatin immunopre-
cipitation sequencing data for 4 key histone modiﬁcations
to determine chromatin state segmentation in an adult
kidney and overlapped chromatin states and chromatin
immunoprecipitation-sequencing signal intensity across
the TSPYL5 locus (Supplementary Figure S6). The
cg22328208 CpG site overlapped with the transcriptionKidney International (2019) 95, 624–635start site of the TSPYL5 gene and is in a transcription start
site chromatin region (1_TssA) in adult kidney tissue.29 It
is part of a CpG island. Histone modiﬁcation intensity in
the region showed a strong enrichment for H3K4me3 (a
mark of high speciﬁcity to promoter regions). The best
eSNP (rs2567772) and mSNP (rs1367917) are 9.1 kb and
23.5 kb downstream from TSPYL5 and map to a weakly
transcribed chromatin state (5_TxWk) and quiescent
chromatin (15_Quies) in adult human kidney, respectively
(Supplementary Table S26). Integrative analysis of high-
resolution (5–10 kb) genome-wide high throughput
chromosome conﬁrmation capture chromatin interaction
data30 showed statistically signiﬁcant physical interactions
between regions proximal to the mSNP and eSNP (or their
proxies) and the promoter region of TSPYL5
(Supplementary Figure S6 and Supplementary Table S27).629
Table 2 | Association between age-related kidney genes and their best eSNPs: cis-expression quantitative locus meta-analysis
of the TRANSLATE Study and TCGA
Chr Gene symbol rsID
Distance from gene to SNP,
base pairs Alleles b SE P value
Permutation
P value FDR
10 PPP1R3C rs7077656 –18,450 A/G –0.428 0.062 5.44E-12 5.00E-04 1.64E-03
8 TSPYL5 rs2567772 –4622 G/A 0.287 0.043 1.58E-11 5.00E-04 1.64E-03
3 LTF rs6763280 0 G/A 0.283 0.043 4.48E-11 5.00E-04 1.64E-03
2 LYG1 rs6734290 20,339 G/T –0.244 0.040 1.46E-09 5.00E-04 1.64E-03
Alleles, reference/alternate allele; b, coefﬁcient from linear regression models; Chr, chromosome; FDR, false discovery rate; permutation P value, P value obtained based on
2000 permutations; rsID, reference SNP ID; SNP, single-nucleotide polymorphism.
c l i n i ca l i nves t iga t i on J Rowland et al.: Genes, aging, and the kidneyDISCUSSION
Our study provides several insights into age-related gene
expression changes within the kidney. First, we identify genes
whose expression not only robustly correlates with age in
independent data sets but also is associated with biochemical/
histologic measures of age-related changes in renal health.
Second, we provide evidence for the key role of common
genetic variants as determinants of lifelong, age-related
changes in the renal signatures of aging. Finally, through
integration of information from the genome, epigenome, and
transcriptome we identify TSPYL5 as a robust gene whose
age-related change in kidney expression is mediated through
genetically determined hypermethylation of its promoter.
Only 6 (31.6%) (EGF, LTF, SLPI, SLC16A5, VIM, and
TSPYL5) of 19 robust signatures of age-related changes in
kidney transcriptome were linked to human aging or age-
related kidney diseases in previous studies. For example,
EGF expression is known to correlate inversely with CKD,
renal ﬁbrosis, and rapidly progressive glomerulonephritis.23,31
Changes in renal expression of 2 other genes (LTF and SLPI)
were linked to acute kidney injury.32,33 LTF is an antibacterial,
anti-inﬂammatory, and antioxidant factor providing an
innate line of defense against a host of injury stimuli.34 SLPI
protects epithelial cells from the effects of inﬂammation and
the activity of endogenous proteolytic enzymes.35,36 To this
end, the identiﬁed increase in the expression of LTF and SLP1
with age may represent a kidney repair mechanism in
response to activation of aging-related processes in that organ.
The degree of overlap between age-related genes and those
that constitute the transcriptomic signatures of kidney injury
identiﬁed before suggests the existence of a commonality in
transcriptional pathways of renal damage repair irrespective
of the initial insult.
Our data link a majority of the replicated age-associated
kidney genes to the functional and structural parameters
of renal health known to deteriorate with age. Indeed, theTable 3 | Associations between TSPYL5 CpG methylation,
TSYL5 renal expression, and chronological age in the
TRANSLATE Study
Chr CpG probe Trait b SE FDR
8 cg22328208 TSPYL5 expression –0.545 0.135 0.019
Age 0.016 0.004 <0.001
b, coefﬁcient from linear regression models; Chr, chromosome; CpG probe, DNA
methylation probe; FDR, false discovery rate.
630age-related decline in glomerular ﬁltration rate affects up to
57% to 85% of individuals in the general population.37–39
Glomerular sclerosis, interstitial ﬁbrosis, tubular atrophy,
and arterial narrowing represent the age-related changes in
the structural microarchitecture of the kidney.39 Their
gradual progression inevitably leads to a loss of functional
nephron reserve and atrophy, increasing the susceptibility of
elderly patients to severe presentations of CKD and other
renal disorders.3 The associations between these phenotypes
and our age-related genes suggest that a majority of the
uncovered signatures are not silent bystanders but more
likely are contributors to the key processes underpinning a
gradual functional and structural involution of renal tissue
with aging.
We also show a powerful effect of the inherited variation in
DNA sequence on the kidney expression of genes related to ag-
ing. Our data suggest that for approximately 1 in 5 renal genes
robustly associated with age, common variants mapping to their
proximity determine the lifelong pattern of their expression in
the kidney. This means that the pace with which kidneys age is
determined at least in part at birth and those who inherited a
genotype promoting steeper expression changes of aging signa-
turesmay be at higher risk of age-related decline in kidney health
(given the demonstrated overlap between age-related changes in
renal gene expression and markers of functional and structural
kidney damage). Thus, prediction of the magnitude of age-
related changes in transcriptome based on genotype could lead
to the development of new important diagnostic avenues.
Indeed, noninvasive genotyping of faster renal aging risk variants
might be an attractive strategy for early screening of age-related
kidney diseases and suitability of organ donation in kidney
transplantation.4
One of the most interesting genes uncovered by our study
is TSPYL5, a member of the nucleosome assembly protein
superfamily known for their role in transcriptional regulation
and cell cycle.40 TSPYL5 was implicated in the processes
operating at the intersection of cellular senescence and
carcinogenesis.40 Speciﬁcally, TSPYL5 was suggested to
impact on p53 expression and the activity of telomerase,41,42
and was predicted to associate with telomere length.43 The
recent in vitro TSPYL5 knockdown experiments in human
pluripotent stem cells showed that silencing of this gene leads
to changes in the expression of numerous pathways, including
those responsible for changes in DNA conformation, epige-
netics, and telomere organization.44 These processes mapKidney International (2019) 95, 624–635
Figure 4 | TSPYL5: associations between renal expression, methylation, age, and genotype. (a) Association between kidney expression of
TSPYL5 and age in the meta-analysis of the TRANScriptome of renaL humAn TissuE (TRANSLATE) Study and The Cancer Genome Atlas (TCGA)
study. Meta P value, level of statistical signiﬁcance from the joint analysis; meta false discovery rate (FDR), the level of statistical signiﬁcance
after the correction for multiple testing. (b) Association between kidney expression of TSPYL5 and its best eSNP (rs256772) in the meta-analysis
of TRANSLATE and TCGA studies. Meta P value, level of statistical signiﬁcance from the meta-analysis; meta FDR, the level of statistical sig-
niﬁcance after the correction for multiple testing. (c) Trajectories of age-related reduction in kidney expression of TSPYL5 stratiﬁed on the
genotype of rs256772 in the combined TRANSLATE and TCGA studies. (d) Association between kidney expression of TSPYL5 and the extent of
renal DNA methylation within the cg22328208 probe in the TRANSLATE Study. P value, nominal level of statistical signiﬁcance; FDR, the level of
statistical signiﬁcance after correction for multiple testing. (e) Association between the extent of renal DNA methylation within the cg22328208
probe and age in the TRANSLATE Study. P value, level of statistical signiﬁcance. (f) Association between the extent of renal DNA methylation
within the cg22328208 probe and its best single-nucleotide variant with effect on methylation (mSNP) (rs1367917). P value, nominal level of
statistical signiﬁcance. (g) Effect of age on the kidney expression of TSPYL5 is mediated through the extent of renal DNA methylation
within cg22328208 in the TRANSLATE Study. (h) Effects of the best eSNP (rs256772) and the best mSNP (rs1367917) on the renal expression of
TSPYL5 are mediated through the extent of renal DNA methylation within cg22328208 in the TRANSLATE Study. (i) The causal effect of
methylation at cg22328208 on kidney expression of TSPYL5 using 6 independent genetic instruments (transcriptionally active single-nucleotide
polymorphisms [SNPs]) in Mendelian randomization by inverse variance weighting (orange line) and weighted median (blue line). The green
dots with arrow bars represent genetic associations with kidney expression of TSPYL5 against genetic associations with cg22328208 methyl-
ation (with 95% conﬁdence intervals). RBINT, rank-based inverse normal transformation.
J Rowland et al.: Genes, aging, and the kidney c l i n i ca l i nves t iga t iononto the basic molecular and cellular underpinnings of aging
including regulation of chromatin architecture, epigenetic
control of transcription, and cellular senescence.45
Our results show that an age-related decrease in the renal
expression of TSPYL5 is most likely mediated directly by CpG
methylation, with the strongest signal mapping to the 5’
region of the gene. Jung et al.46 determined that this segment
of TSPYL5 including exon 1 contains the transcription start
site and lies within a CpG island. This was supported by our
analysis in silico. The association between the methylation and
expression of TSPYL5 has been reported previously in other
human tissues including both apparently healthy and diseased
tissues.47,48 The methylation of TSPYL5 also was associatedKidney International (2019) 95, 624–635with other age-related conditions including Huntington’s
disease.49 Notably, the degree of hypermethylation of TSPYL5
promoter in the kidney remains under genetic control and is
linked causally to the renal expression of this gene, but the
strongest mSNP is located more than 20,000 base pairs from
the TSPYL5 promoter. Similar intronic/intergenic SNPs
distant to the methylated CpG sites were shown as the reg-
ulators of their methylation in previous studies.47 Our in silico
studies further suggest that long-range chromatin interactions
between the chromatin segments overlapping with the
TSPYL5 promoter and the distant regions where the best
mSNP maps are plausible explanations for the detected
associations.631
c l i n i ca l i nves t iga t i on J Rowland et al.: Genes, aging, and the kidneyCertainly, there were limitations of our analyses. The
noncancerous renal tissues analyzed in both the TRANSLATE
and TCGA cohorts were sourced from nephrectomies per-
formed for primary kidney cancers. However, our previous
investigations showed that the presence of cancer does not
affect the transcriptome of kidney tissue collected from the
cancer-unaffected part of the kidney.50 Moreover, the tissues
within the replication resource that validated the associations
between 19 renal genes and age came mostly from noncancer
patients. Thus, it is unlikely that the history of renal cancer in
the donors had a confounding effect on our results. We also
appreciate the limited size of our kidney methylation data set
in the TRANSLATE Study. The power limitation was the most
likely reason why our study uncovered only 1 independent
association between age-related gene expression and methyl-
ation after the stringent correction for multiple testing.
However, 63% of our renal signatures showed nominally
signiﬁcant associations with kidney DNA methylation
(Supplementary Table S20) and/or were correlated with CpG
methylation in other human tissues.47,51 Finally, we
acknowledge the limitations of the quantitative analysis of
TSPYL5 immunostaining restricted to 9 human kidneys.
These samples represent only a small fraction of the set of
renal tissues from more than 500 individuals examined at the
transcriptome level. Thus, the arising results likely were un-
derpowered for deﬁning changes in the target protein with
age. In the future, the complete spectrum of protein changes
will need to be measured in several hundreds of samples using
high-throughput proteomic approaches.
Despite these caveats, our analysis linked age-related changes
in kidney expression to genome and epigenome and show
compelling evidence for promoter hypermethylation as the
causal mechanism for an age-related decrease in renal expression
of one of the uncovered signatures.
We stress that our discovery analysis was based exclusively
on RNA-seq, the state-of-the-art method of RNA proﬁling to
measure transcript abundance. We also applied stringent
statistical methods in the analyses of association between gene
signatures and aging. Previous studies relying on much
smaller numbers of kidney samples, collected largely in a
similar manner to the TRANSLATE Study and TCGA but
proﬁled using microarrays, used less-stringent statistical
thresholds and lacked an independent replication. Therefore,
it is not possible to exclude the role of a type 1 error in
relation to approximately 1000 reported associations with age
in these investigations.8 Most notably, the magnitude of dis-
covery for age-associated kidney genes in our analysis is
consistent with that for a majority of nonrenal GTEx tissues
processed by RNA-seq and examined using similar statistical
pipelines. Therefore, we are conﬁdent that the identiﬁed genes
represent robust signatures of age on kidney transcriptome.
In summary, with 260 kidneys examined at the discovery stage
and more than 300 kidneys analyzed in the replication phase, our
study was a large analysis of changes in the human renal tran-
scriptome in relation to aging. We uncovered new robust gene
signatures of kidney aging, showed their relevance to age-related632decline in renal health, and demonstrated the potential of inte-
grative -omics to uncover new regulatory mechanisms under-
pinning age-related changes in renal gene expression.METHODS
Discovery analysis of association between gene expression and
chronological age was conducted using data from 2 projects: the
TRANSLATE Study50,52 and TCGA.53 First, separate analyses were
performed on the 2 data sets, then the results were combined
using an inverse-variance method. Kidney transcriptome proﬁling
in both projects was conducted by RNA-seq. Replication analysis
was conducted using data from Nephroseq, a platform of
comprehensive renal disease gene expression data sets.22 Within
Nephroseq, we performed an analysis of age-associated genes using
a collection of apparently healthy renal tissue from Rodwell et al.,8
and 2 data sets based on specimens from patients with kidney
disease by Ju et al.23 and Sampson et al.,24 separately in kidney
cortex and medulla. The number of age-associated genes in 42
nonrenal tissues and the kidney speciﬁcity of replicated genes was
examined using the data from the GTEx project.54,55 Replicated
genes were examined further for association with renal function
and structure, age-related renal changes in rodents and cell lines,
common genotypes (expression quantitative trait locus analysis),
associations with CKD, and kidney DNA methylation. Kidney
tissues immunostaining was performed using 2 antibodies raised
against TSPYL5. Each antibody provided similar patterns on
kidney cortex sections from 9 TRANSLATE Study individuals,
spanning an age range of 30 to 81 years. The relevant DNA
methylation sites were examined for association with chronolog-
ical age and genotype (methylation quantitative trait locus
analysis).
Gene expression was quantiﬁed in transcripts per million and
normalized using logarithmic transformation, quantile normali-
zation, and rank-based inverse normal transformation in both the
TRANSLATE Study and TCGA. The extent of technical variation
in the normalized gene expression data was determined using the
probabilistic estimation of the expression residual method.56 All
association analyses were conducted using multiple linear
regression controlling for sex, the top 3 genotype principal
components, and technical factors if appropriate. The statistical
signiﬁcance was determined based on the false discovery rate
either using the Benjamini–Hochberg method or the method of
Storey et al.57,58 We performed causal inference and mediation
analysis and Mendelian randomization to explore the causal
drivers of changes in gene expression. Bioinformatic analyses
consisted of regulatory characterization of age-associated genes
(Roadmap Epigenomics chromatin state), examining their organ
speciﬁcity (Human Protein Atlas25) and long-range chromatin
interactions (high throughput chromosome conﬁrmation capture
data59). Further details regarding the methods are provided in the
Supplementary Data.DISCLOSURE
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Figure S1. Analysis of association between age and kidney gene
expression, a meta-analysis of the TRANScriptome of renaL humAn Tis-
suE (TRANSLATE) Study and The Cancer Genome Atlas (TCGA). b, a co-
efﬁcient of regression from the meta-analysis, is plotted on the X axis,
statistical signiﬁcance [-log10 (P value)] is plotted on the Y axis (inversely
log-transformed for ease of interpretation), the dotted line shows a
threshold for correction for multiple testing [false discovery rate (FDR),
5%], genesupregulatedwithageat FDR<0.05are shown ingreen,genes
down-regulated with age at FDR < 0.05 are shown in red.
Figure S2. Analysis of association between replicated age-associated
genes and 5 measures of renal health in the TRANScriptome of renaL
humAn TissuE (TRANSLATE) Study. Different colors show themagnitude
of statistical signiﬁcance for association between the expression of each
individual gene and a given phenotype. Row 1: Genes whose expression
increased with age in the TRANSLATE Study/The Cancer Genome Atlas
(TCGA) analysis are shown in dark green. Genes whose expression
decreasedwith age in the TRANSLATE Study/TCGA analysis are shown in
red. Rows2 to 6:Geneswhoseexpression is associatedpositivelywith the
given renal phenotype after correction for multiple testing [false dis-
covery rate (FDR), < 5%] are shown in dark green. Genes whose
expression is associated positively with the given renal phenotype at the
nominal level (P< 5%) are shown in light green.Geneswhose expression
is associated inverselywith thegiven renal phenotypeafter correction for
multiple testing (FDR,<5%) are shown in red. Geneswhose expression is
associated inverselywith the given renal phenotype at the nominal level
(P < 5%) are shown in orange. Genes whose expression was not asso-
ciated signiﬁcantly with the given renal phenotype are shown in gray.
The estimated glomerular ﬁltration rate (eGFR) was calculated based on
the EPI-CKD formula.
Figure S3. Association of renal expression of TSPYL5 with age in rats.
P value: level of statistical signiﬁcance from analysis of variance
(ANOVA).
Figure S4. Analysis of the difference in immunohistochemistry-derived
signal intensity for kidney TSPYL5 between younger (age, #60 yr) and
older (age,>60 yr) individuals from the TRANScriptome of renaL humAn
TissuE (TRANSLATE) Study. N, number of individuals; P value, level of
statistical signiﬁcance using the Mann–Whitney U test.
Figure S5. Associations between age, renal expression of signature
genes, and their best eSNPs in the TRANScriptome of renaL humAn
TissuE (TRANSLATE) Study and The Cancer Genome Atlas (TCGA). (A)
Associations between the renal expression of each gene and age in
the meta-analysis of the TRANSLATE Study and TCGA. Meta P value,
level of statistical signiﬁcance from the meta-analysis of both studies;
meta false discovery rate (FDR), the level of statistical signiﬁcance
after correction for multiple testing. (B) Renal expression of each gene
stratiﬁed on the genotype of the best eSNP in the meta-analysis of
the TRANSLATE Study and TCGA. meta P value, level of statistical
signiﬁcance from the meta-analysis of both studies; meta FDR, the
level of statistical signiﬁcance after correction for multiple testing. (C)
Trajectories of age-related changes in renal expression of the 4 genes
stratiﬁed on the genotype of the best respective eSNP in the meta-
analysis of the TRANSLATE Study and TCGA.Kidney International (2019) 95, 624–635Figure S6. TSPYL5 functional annotation to the locus on
chromosome 8. Hi-C chromatin interactions are shown as gray
arcs, the intensity of gray is determined by the number of times
the interaction was observed. The best mSNP and eSNP are shown
as large points in blue and yellow, respectively. mSNP and eSNP
statistical proxies (r2 > 0.8 in 1000 Genomes European individuals)
are shown as smaller points in blue and yellow, respectively. The
CpG site (cg22328208) is shown in dark purple and its parent CpG
island (chromosome 8: 98289605-98290404; 25% CpG content) is
shown in light purple. The TSPYL5 gene is shown as a gray region,
with the coding exon black. Chromatin state information from
adult kidney tissue is shown below the gene, red denotes tran-
scription start site regions, yellow indicates enhancer regions, and
green indicates transcribed regions. Input histone modiﬁcation
chromatin immunoprecipitation (ChIP)-seq data signal is shown at
the bottom; H3K4me3 is shown in red, H3K4me1 is shown in
yellow, and H3K36me3 in green. The histone modiﬁcation signal is
calculated as the Loess smoothed density of ChIP-seq reads across
the region, colors are from Roadmap Epigenomics.
Table S1. Meta-analysis of association between renal genes and age
in the TRANSLATE Study and TCGA.
Table S2. Functional characterization of genes associated with kidney
aging in the TRANSLATE Study and TCGA.
Table S3. Effect of adjustment for comorbidities (body mass index,
hypertension, and diabetes) on association between age and renal
expression of 37 genes from the discovery analysis–sensitivity analysis in
the TRANSLATE Study.
Table S4. Replication of associations between renal genes and age in
the renal cortex/glomerular compartment: meta-analysis of 3 sepa-
rate studies from Nephroseq resource.
Table S5. Replication of associations between renal genes and age in
the renal medulla/tubulointerstitial compartment: meta-analysis of 3
separate studies from Nephroseq resource.
Table S6. GTEx tissues included in the analysis of association
between age and gene expression.
Table S7. Demographic characteristics of individuals from GTEx.
Table S8. Analysis of association between age and expression of age-
related renal genes in nonrenal GTEx tissues.
Table S9. Sensitivity analyses of association between age and
expression of age-related renal genes in nonrenal GTEx tissues.
Table S10. Analysis of association between 19 robust age-related
genes and estimated glomerular ﬁltration rate in the TRANSLATE
Study.
Table S11. Analysis of association between 19 robust age-related
genes and glomerular sclerosis in the TRANSLATE Study.
Table S12. Analysis of association between 19 robust age-related
genes and interstitial ﬁbrosis in the TRANSLATE Study.
Table S13. Analysis of association between 19 robust age-related
genes and tubular atrophy in the TRANSLATE Study.
Table S14. Analysis of association between 19 robust age-related
genes and arterial/arteriolar narrowing in the TRANSLATE Study.
Table S15. Cross-species validation of 19 genes showing age-related
changes in kidney expression: analysis of murine model of renal
aging.
Table S16. Gene signatures of kidney aging and their best eSNPs:
meta analysis of the TRANSLATE Study and TCGA.
Table S17. Gene signatures of kidney aging and their eSNPs: meta-
analysis of the TRANSLATE Study and TCGA.
Table S18. Functional annotations of the 4 best eSNPs associated
with renal expression of age-related gene signatures.
Table S19. Association of eSNPs (for PPP1R3C, TSPYL5, LYG1, and
LTF) with estimated glomerular ﬁltration rate in CKDGen genome-
wide association study.
Table S20. CpG sites associated with renal expression of age-related
genes in the TRANSLATE Study.
Table S21. The effect of TSPYL5 methylation on its expression: cell
lines.633
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associated with renal expression of TSPYL5 in the TRANSLATE Study.
Table S23. Analysis of association between age and the extent of
kidney DNA methylation at the TSPYL5 promoter: replication in TCGA
study.
Table S24. Association between age- and gene-expression–related
CpG sites and genetic variants in-cis: all signiﬁcant mSNPs from mQTL
analysis in the TRANSLATE Study (eQTL best eSNP is highlighted).
Table S25. Overlap between mSNPs and eSNPs for TSPYL5.
Table S26. Functional annotation of the best mSNP for cg22328208
in the TRANSLATE Study.
Table S27. Chromatin interaction data from the 4DGenome database
used in Figure S6.
Table S28. Postimputation quality control for eQTL analysis in the
TRANSLATE Study and TCGA.
Table S29. Postimputation quality control for mQTL analysis in the
TRANSLATE Study.
Supplementary material is linked to the online version of the paper at
www.kidney-international.org.REFERENCES
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